Your browser doesn't support javascript.
loading
Once-weekly  semaglutide  for obesity  or overweight: A systematic review and meta-analysis.
He, Ke; Guo, Qing; Zhang, Haijuan; Xi, Wang; Li, Jingxin; Jing, Zeng.
  • He K; Department of Pharmacy, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Guo Q; Department of Obstetrics and Gynecology, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Zhang H; Department of Obstetrics and Gynecology, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Xi W; Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li J; Department of Chinese Pharmacy, Hebei Maternity Hospital, Shijiazhuang, China.
  • Jing Z; Department of Pharmacy, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
Diabetes Obes Metab ; 24(4): 722-726, 2022 04.
Article en En | MEDLINE | ID: mdl-34866313

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article